Drugs & medicalClass II

RemedyRePack Inc. recalls Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#:…

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Read the official notice →
Date
2025-05-14
Country
United States
Brand
RemedyRepack
Product
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#:…
Classification
Class II
Units
Within U.S - PA, VA, FL.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More RemedyRepack recalls

  1. 2025-04-30
  2. US
  3. 2025-02-12
  4. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged…

    CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

    FDA · DrugRemedyRepack Inc.FLOfficial notice →
  5. 2025-01-01
  6. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx…

    CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRemedyRepack Inc.Nationwide in the USOfficial notice →
  7. 2024-07-24
  8. US
  9. 2024-06-19
  10. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source…

    Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

    FDA · DrugRemedyRepack Inc.Product was distributed to one medical facility.Official notice →
  11. 2024-05-15
  12. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a)…

    Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol

    FDA · DrugRemedyRepack Inc.Nationwide in the USAOfficial notice →
All 17 RemedyRepack recalls →

Other drugs & medical recalls in the United States

  1. 2025-05-14
  2. US
    Drugs & medicalClass I

    Smiths Medical ASD, Inc. recalls CADD-Solis HPCA Ambulatory Infusion Pump; Model/Number: 21-2111-0402-09-KYO 21-2111-0402-09-KYO CADD SOLIS PIB PUMP FOR CLINICAL…

    Affected pumps may trigger an erroneous (false) Upstream Occlusion Alarm under certain conditions, which will interrupt an active infusion. Interruption or delay of therapy can lead to serious patient injury or death.

    FDA · DeviceSmiths Medical ASD, Inc.Worldwide - US nationwide distribution.Official notice →
  3. US
    Drugs & medicalClass I

    Smiths Medical ASD, Inc. recalls CADD Solis HSPCA Pump ***Updated 5/27/26*** Scope updated to apply specifically to customers using the wireless system. Affected…

    Pumps may experience Wireless Connection Modules intermittent connection alarms, which will interrupt an active infusion. Interruption or delay of therapy can lead to serious patient injury or death.

    FDA · DeviceSmiths Medical ASD, Inc.Worldwide - US Nationwide distribution.Official notice →
  4. US
    Drugs & medicalClass II

    BSO LLC recalls TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or…

    Presence of Particulate Matter: Glass particles were found in pellet vials.

    FDA · DrugBSO LLCNationwide in the USAOfficial notice →
  5. US
  6. US
  7. US
    Drugs & medicalClass II

    BRS Analytical Services, LLC recalls Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE,…

    cGMP deviations and lack of assurance of sterility.

    FDA · DrugBRS Analytical Services, LLCNationwide in the USAOfficial notice →
See all drugs & medical recalls →